1. Design and manufacture of brachytherapy system for the treatment of non-resectable pancreatic cancer, in combination with gemcitabine based chemotherapy
Expiry date: 26/May/2024
2. The design, development and control of manufacture of radioactive particles in the area of oncology.
expiry date: 15/April/2023
3. Oncosil system
Expiry date:26/May/2024
Who know the which company is manufacture the device and radioactive particles?
As COVID-19, many countries are lockdown.
It will be delay commercialised.
1. Design and manufacture of brachytherapy system for the...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $27.18M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 12184962 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 5541905 | 5 |
View Market Depth
| Last trade - 10.26am 24/07/2024 (20 minute delay) ? |
| OSL (ASX) Chart |
Day chart unavailable